| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |